Senior Evidence Synthesis Lead - Remote

American Chemical Society; United States; Remote; USD 90.000 - 105.000; Vollzeit

Benefits dieser Stelle

Generous paid time off

Medical, dental benefits

Retirement benefits

Professional development programs

Zusammenfassung

American Cancer Society seeks a Senior Research Associate, Evidence Synthesis to lead high‑quality systematic reviews informing early cancer detection guidelines. You will serve as a working PI or co‑PI, shape evidence needs with CrEST leadership, and drive all stages from protocol to dissemination.

You will supervise staff, manage multiple reviews, adhere to deadlines, and mentor team members while communicating with diverse experts to advance ACS guidelines and stay at the forefront of cancer

Qualifikationen

• Master’s degree in public health, health policy/services, or related field with 5+ years leading systematic reviews.
• Experience conducting systematic evidence reviews and health technology assessments.
• Ability to translate complex findings into actionable written reports and guidance.

Aufgaben

• Lead design, conduct, and dissemination of systematic evidence reviews for cancer screening guidelines.
• Supervise and mentor junior staff; coordinate multiple projects and deadlines.
• Communicate findings to internal/external stakeholders and prepare journal-ready manuscripts.

Kenntnisse

Organizational skills

Written communication

Project leadership

Evidence synthesis

Ausbildung

Master’s degree in public health

Tools

DistillerSR

EndNote

MS Office (Word, Excel, PowerPoint)

R / Tableau

Jobbeschreibung

American Cancer Society seeks a Senior Research Associate, Evidence Synthesis to lead high‑quality systematic reviews informing early cancer detection guidelines. You will serve as a working PI or co‑PI, shape evidence needs with CrEST leadership, and drive all stages from protocol to dissemination.

You will supervise staff, manage multiple reviews, adhere to deadlines, and mentor team members while communicating with diverse experts to advance ACS guidelines and stay at the forefront of cancer